绥美凯效果好吗

Is India's Emcure Pharmaceuticals effective? Emcure Pharmaceuticals India was founded in 1983 with the original intention of creating a healthcare company to meet a wide range of healthcare needs. The company's commitment and drive have driven its growth from a single manufacturing facility during Genesis to a collection of world-class manufacturing facilities across API, formulations and biotech. Suimeike produced by Emcure is very popular among patients because of its relatively low price. However, some patients want to know whether Suimeike from Emcure Pharmaceutical Company of India is effective?

Suimeikai is a compound preparation. Each tablet contains dolutegravir sodium (calculated as dolutegravir) 50mg, abacavir sulfate (calculated as abacavir) 600mg and lamivudine 300mg. It is suitable for the treatment of adults infected with human immunodeficiency virus (HIV) and adolescents over 12 years old (with a weight of at least 40kg).

One tablet of Suimeikai is a complete treatment plan. Its advantages are: 1. The virus suppression effect is obvious. 2. It has high drug resistance and is not prone to drug resistance. 3. The probability of side effects is low and it is well tolerated. 4. It is simple to take, once a day, no need to consider food factors. It greatly improves patients' medication compliance.

In the real world, antiviral treatment-naïve patients treated with DTG have a lower proportion of central nervous system-related (CNS) adverse events than the four drugs RAL (Ascent), DRV/r (darunavir), EFV (efavirenz) and ATV/r (atazanavir). Therefore, the drug safety of Suimeike, which is based on DTG integrase inhibitors, has proven to be controllable.

The above is the effect introduction, I hope it will be helpful to you.

Recommended related hot articles: /newsDetail/87268.html